Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
007460.KS Stock Summary
Top 10 Correlated ETFs
007460.KS
In the News
007460.KS Financial details
Company Rating
Buy
Market Cap
354.75B
Income
-77.7B
Revenue
137.99B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
367
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-2.96
Forward P/E
-
PEG
-0.24
P/S
2.57
P/B
1.31
P/C
-
P/FCF
-2.56
Quick Ratio
-
Current Ratio
2.88
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-483.92
EPS next Y
-
EPS next Q
-
EPS this Y
167.16%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.8%
Revenue last 5Y
8.95%
Revenue Q/Q
-3.04%
EPS Q/Q
-27.19%
-
-
-
-
SMA20
7.82%
SMA50
-7.06%
SMA100
-18.32%
Inst Own
-
Inst Trans
-
ROA
-13%
ROE
-35%
ROC
-0.16%
Gross Margin
17%
Oper. Margin
-61%
Profit Margin
-56%
Payout
-
Shs Outstand
252.67M
Shs Float
92.42M
-
-
-
-
Target Price
-
52W Range
1207.0-6328.7344
52W High
-77.81%
52W Low
+16.32%
RSI
52.41
Rel Volume
0.53
Avg Volume
2.04M
Volume
1.09M
Perf Week
4.15%
Perf Month
10.12%
Perf Quarter
-36.31%
Perf Half Y
-29.4%
-
-
-
-
Beta
0.60797
-
-
Volatility
59.26%, 66.1%
Prev Close
0.86%
Price
1404
Change
-1.89%
007460.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 1K | 1.71K | 2.25K | 2.44K | 389.43 | |
Net income per share | -631.71 | 400.63 | -577.5 | -215.97 | -576.99 | |
Operating cash flow per share | -29.3 | -24.39 | 398.34 | -148.68 | -564.1 | |
Free cash flow per share | -108.77 | -203.15 | 343.17 | -185.21 | -687.46 | |
Cash per share | 2.36K | 3.82K | 4.2K | 2.76K | 235.89 | |
Book value per share | 3.85K | 5.89K | 5.64K | 5.8K | 1.07K | |
Tangible book value per share | 3.84K | 11.23K | 12.13K | 12.12K | 2.22K | |
Share holders equity per share | 3.85K | 5.89K | 5.64K | 5.8K | 1.07K | |
Interest debt per share | 3.74K | 2.06K | 1.61K | 1.56K | 497.55 | |
Market cap | 1175.4B | 373.87B | 346.98B | 292.52B | 115.08B | |
Enterprise value | 1284.95B | 387.15B | 336.02B | 309.12B | 162.21B | |
P/E ratio | -36.61 | 20.4 | -10.62 | -23.4 | -0.99 | |
Price to sales ratio | 23.03 | 4.78 | 2.73 | 2.07 | 1.47 | |
POCF ratio | -789.27 | -335.11 | 15.4 | -33.99 | -1.01 | |
PFCF ratio | -212.61 | -40.23 | 17.87 | -27.29 | -0.83 | |
P/B Ratio | 6.01 | 1.39 | 1.09 | 0.87 | 0.54 | |
PTB ratio | 6.01 | 1.39 | 1.09 | 0.87 | 0.54 | |
EV to sales | 25.17 | 4.95 | 2.64 | 2.19 | 2.07 | |
Enterprise value over EBITDA | -199.18 | 8.66 | 33.83 | -48.3 | -2.49 | |
EV to operating cash flow | -862.83 | -347.02 | 14.91 | -35.92 | -1.43 | |
EV to free cash flow | -232.43 | -41.66 | 17.31 | -28.84 | -1.17 | |
Earnings yield | -0.03 | 0.05 | -0.09 | -0.04 | -1.01 | |
Free cash flow yield | 0 | -0.02 | 0.06 | -0.04 | -1.2 | |
Debt to equity | 0.87 | 0.32 | 0.27 | 0.24 | 0.42 | |
Debt to assets | 0.43 | 0.13 | 0.1 | 0.1 | 0.15 | |
Net debt to EBITDA | -16.98 | 0.3 | -1.1 | -2.59 | -0.72 | |
Current ratio | 1.42 | 3.19 | 5.11 | 4.37 | 2.35 | |
Interest coverage | 0.08 | 4.53 | 1.08 | -0.23 | -11.54 | |
Income quality | 0.05 | -0.06 | -0.69 | 0.69 | 0.98 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.03 | 0.03 | 0.03 | 0.37 | |
Research and developement to revenue | 0.09 | 0.02 | 0.01 | 0.01 | 0.49 | |
Intangibles to total assets | 0 | 0.01 | 0 | 0 | 0.02 | |
Capex to operating cash flow | 2.71 | 7.33 | -0.14 | 0.25 | 0.22 | |
Capex to revenue | -0.08 | -0.1 | -0.02 | -0.01 | -0.32 | |
Capex to depreciation | -1.99 | -2.52 | -0.72 | -0.5 | -0.87 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0.01 | |
Graham number | 7.39K | 7.29K | 8.56K | 5.31K | 3.73K | |
ROIC | 0.01 | 0.09 | 0.01 | -0.01 | -0.23 | |
Return on tangible assets | -0.08 | 0.03 | -0.04 | -0.02 | -0.2 | |
Graham Net | -1.52K | 1.18K | 1.8K | 872.65 | -301.5 | |
Working capital | 41.51B | 238.45B | 349.41B | 373.57B | 121.64B | |
Tangible asset value | 195.42B | 513.89B | 686.3B | 701.3B | 447.58B | |
Net current asset value | -58.31B | 217.47B | 290.24B | 364.58B | 72.73B | |
Invested capital | 0.87 | 0.32 | 0.27 | 0.24 | 0.42 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1.55B | 824.36M | 1.55B | 1.65B | 3.02B | |
Average inventory | 4.79B | 11.29B | 17.35B | 19.1B | 41.18B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 10.22 | 5.72 | 6.16 | 21.16 | |
Days of inventory on hand | 45.2 | 107.86 | 68.14 | 69.35 | 310.76 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 35.72 | 63.76 | 59.27 | 17.25 | |
Inventory turnover | 8.07 | 3.38 | 5.36 | 5.26 | 1.17 | |
ROE | -0.16 | 0.07 | -0.1 | -0.04 | -0.54 | |
Capex per share | -79.47 | -178.76 | -55.17 | -36.52 | -123.36 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 624.8 | 530.92 | 125.64 | 184.31 | 0 | |
Net income per share | 3.37 | -132.27 | -93.58 | -149.34 | 0 | |
Operating cash flow per share | -10.1 | 327.91 | -509.78 | -116.91 | 0 | |
Free cash flow per share | -19.09 | 321.85 | -595.51 | -141.28 | 0 | |
Cash per share | 1.83K | 1.53K | 272.41 | 235.89 | 0 | |
Book value per share | 5.09K | 5.49K | 530.31 | 1.07K | 0 | |
Tangible book value per share | 10.54K | 10.71K | 2.16K | 2.22K | 0 | |
Share holders equity per share | 5.09K | 5.49K | 530.31 | 1.07K | 0 | |
Interest debt per share | 1.17K | 335.19 | 377.64 | 460.23 | 0 | |
Market cap | 306.98B | 360.06B | 631.08B | 115.08B | 0 | |
Enterprise value | 337.07B | 276.22B | 655.97B | 162.21B | 0 | |
P/E ratio | 339.25 | -9.69 | -7.65 | -0.96 | 0 | |
Price to sales ratio | 7.32 | 9.66 | 22.8 | 3.1 | 0 | |
POCF ratio | -452.88 | 15.64 | -5.62 | -4.89 | 0 | |
PFCF ratio | -239.65 | 15.94 | -4.81 | -4.05 | 0 | |
P/B Ratio | 0.9 | 0.93 | 5.4 | 0.54 | 0 | |
PTB ratio | 0.9 | 0.93 | 5.4 | 0.54 | 0 | |
EV to sales | 8.04 | 7.41 | 23.7 | 4.37 | 0 | |
Enterprise value over EBITDA | -186.14 | -78.05 | -31.24 | -12.93 | 0 | |
EV to operating cash flow | -497.27 | 12 | -5.84 | -6.9 | 0 | |
EV to free cash flow | -263.14 | 12.22 | -5 | -5.71 | 0 | |
Earnings yield | 0 | -0.03 | -0.03 | -0.26 | 0 | |
Free cash flow yield | 0 | 0.06 | -0.21 | -0.25 | 0 | |
Debt to equity | 0.22 | 0.05 | 0.68 | 0.42 | 0 | |
Debt to assets | 0.09 | 0.03 | 0.13 | 0.15 | 0 | |
Net debt to EBITDA | -16.61 | 23.69 | -1.19 | -3.76 | 0 | |
Current ratio | 5.04 | 13.61 | 3 | 2.35 | 2.88 | |
Interest coverage | 0 | -0.67 | -10.94 | -10.32 | -2.09 | |
Income quality | -3 | -2.48 | 1.46 | 0.78 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 1.72 | 0.19 | 0.74 | |
Research and developement to revenue | 0.01 | 0.03 | 0 | 0.05 | 0 | |
Intangibles to total assets | 0 | 0 | 0.02 | 0.02 | 0 | |
Capex to operating cash flow | 0.89 | -0.02 | 0.17 | 0.21 | 0 | |
Capex to revenue | -0.01 | -0.01 | -0.68 | -0.13 | 0 | |
Capex to depreciation | -0.66 | -0.46 | -0.98 | -0.67 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | -0.01 | 0 | |
Graham number | 621.04 | 4.04K | 1.06K | 1.9K | 0 | |
ROIC | 0 | 0 | -0.08 | -0.05 | -0.03 | |
Return on tangible assets | 0 | -0.01 | -0.03 | -0.05 | -0.03 | |
Graham Net | 334.76 | 1.05K | -148.3 | -301.5 | 0 | |
Working capital | 410.16B | 463.11B | 148.01B | 121.64B | 134.98B | |
Tangible asset value | 707.48B | 751.86B | 476.68B | 447.58B | 455.79B | |
Net current asset value | 399.43B | 453.67B | 99.27B | 72.73B | 71.16B | |
Invested capital | 0.22 | 0.05 | 0.68 | 0.42 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 2.01B | 2.37B | 3.87B | 4.68B | 2.09B | |
Average inventory | 22.3B | 24.33B | 42.46B | 60.71B | 30.73B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 6.01 | 7.75 | 22.86 | 9.84 | 0 | |
Days of inventory on hand | 66 | 75.1 | 265.19 | 144.57 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 14.97 | 11.61 | 3.94 | 9.14 | 0 | |
Inventory turnover | 1.36 | 1.2 | 0.34 | 0.62 | 0 | |
ROE | 0 | -0.02 | -0.18 | -0.14 | -0.1 | |
Capex per share | -8.99 | -6.06 | -85.73 | -24.37 | 0 |
007460.KS Frequently Asked Questions
What is Aprogen Medicines Inc. stock symbol ?
Aprogen Medicines Inc. is a KR stock and trading under the symbol 007460.KS
What is Aprogen Medicines Inc. stock quote today ?
Aprogen Medicines Inc. stock price is $1404 today.
Is Aprogen Medicines Inc. stock public?
Yes, Aprogen Medicines Inc. is a publicly traded company.